Funding Details
- Awarder
- YCombinator
- Date Award
- July 22, 2021
- Vertical
- Healthcare,Therapeutics
- Funding URL
- View Funding Page
- Valuation
-
$0
Company Info
- Founding Year
- 2021
- Company Description
- We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
- Market
- Healthcare
- Location
-
Boston,
MA,
USA
- Coinvestors
- YCombinator
Links